Citation: B. Pieske, Alterations in excitation-contraction coupling and potential gene therapy targets in failing human hearts, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 5-25
Citation: Mt. Lohse et S. Engelhardt, Cardiac overexpression of beta-adrenergic receptors, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 26-38
Citation: Ag. Schmidt et Eg. Kranias, Genetic approaches to elucidate the regulatory role of phospholamban in the heart, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 39-52
Authors:
Janssen, PML
Lehnart, SE
Donahue, JK
Prestle, J
Marban, E
Hasenfuss, G
Citation: Pml. Janssen et al., Adenovirus-mediated transfection of multicellular cardiac preparations, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 112-125
Authors:
Eschenhagen, T
Fink, C
Rau, T
Remmers, U
Weil, J
Zimmermann, WH
Aigner, S
Eppenberger, HM
Wakatsuki, T
Elson, EL
Citation: T. Eschenhagen et al., Transfection studies using a new cardiac 3D gel system, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 144-156
Citation: Dj. Beuckelmann et al., Cellular mechanisms of cardiac arrhythmias - do they play a role in heart failure?, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 157-179
Citation: Da. Kass et al., Neurohumoral modulation of metalloproteinases in cardiac failure: impact on remodeling, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 247-261
Citation: I. Morano, Modulation of cardiac function by essential myosin light chains in health and disease, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 285-297
Citation: Ce. Murry et al., Myocardial infarction, infarct repair, and strategies for muscle regeneration, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 298-315
Authors:
Reinecke, H
MacDonald, GH
Hauschka, SD
Murry, CE
Citation: H. Reinecke et al., Cardiomyocytes can induce rhythmic contraction of skeletal muscle cells. Potential use for infarct repair, MOLECULAR APPROACHES TO HEART FAILURE THERAPY, 2000, pp. 316-332